Creating a Covariate Candidate Matrix

Why Make a Covariate Candidate Matrix?

A covariate list is not yet a covariate model plan. A list might contain body weight, renal function, and sex, but it does not say which parameter each covariate may explain, why the relationship is plausible, whether the required measurements are available, or what result would be tested. In a nonlinear mixed-effects model, those distinctions matter: a covariate may plausibly affect clearance but not volume, and its expected effect on one parameter may differ from its effect on another.

A candidate matrix makes each proposed relationship explicit before model selection. It is a planning and documentation tool, not a statistical test and not evidence that any listed relationship is present. The earlier material on translating pharmacology into covariate hypotheses provides the scientific starting point; the matrix records those hypotheses in a form that can be checked and implemented consistently.

Definition: A covariate candidate matrix is a structured record of proposed relationships between model parameters and covariates. For each parameter–covariate pair, it documents the scientific rationale, data availability, expected direction or contrast, and planned statistical test or model comparison.

Let \(\theta_k\) denote a population parameter of interest, such as typical clearance, and \(x_j\) a candidate covariate, such as body weight. One candidate is the relationship between that particular \(\theta_k\) and \(x_j\), not merely the presence of \(x_j\) somewhere in the model. For individual \(i\), a possible continuous-covariate relationship is:

\theta_{k,i}=\theta_{k,\mathrm{ref}}\left(\frac{x_{ij}}{x_{j,\mathrm{ref}}}\right)^{\beta_{kj}}

Here \(\theta_{k,\mathrm{ref}}\) is the parameter value at a stated reference covariate value, and \(\beta_{kj}\) determines the direction and magnitude of the relationship. This is one possible parameterization, not a default that must be used for every covariate. For a categorical covariate, a candidate may instead be a difference between a stated category and a reference category.

What Each Entry Should Record

Use one row per proposed parameter–covariate relationship, or use a table with parameters as rows and covariates as columns if each cell can retain the same supporting details. A compact label such as “weight–clearance” is not enough on its own. A useful record includes the following:

Parameter and covariate: name the exact model parameter and the covariate, including units and the relevant time point or summary if those matter.
Scientific rationale: state why the relationship is plausible for this parameter in this setting. Distinguish biological or pharmacological reasoning from a purely exploratory suggestion.
Availability: say whether the needed measurement is recorded for the intended analysis and where it comes from. If availability is uncertain, mark it as uncertain rather than assuming it is usable.
Expected direction or contrast: specify what increase in the covariate is expected to do to the parameter, or which category is expected to have the higher or lower value. Name the reference value or category.
Planned test: state the parameterization and the planned null comparison, such as testing whether the covariate coefficient is zero by a one-degree-of-freedom likelihood-ratio comparison. For a multi-level factor or multi-parameter effect, state that the planned comparison is joint and identify its degrees of freedom when known.

The direction entry needs particular care. “Higher weight increases clearance” refers to the parameter itself; it does not necessarily mean the covariate coefficient is positive under every coding. In the power model above, if \(x_{ij}>x_{j,\mathrm{ref}}\), a positive \(\beta_{kj}\) implies a larger \(\theta_{k,i}\) than \(\theta_{k,\mathrm{ref}}\). If the covariate is centered, log-transformed, or coded with a different reference, write the expected direction in terms of the actual contrast being modeled.

Worked Examples

Worked Example: Recording a Continuous Covariate Candidate

Hypothetical setting. A population pharmacokinetic analysis uses a one-compartment model with typical clearance \(CL\) in L/h. Body weight is recorded at baseline in kg. The scientific team proposes that higher body weight may be associated with higher clearance and chooses a power relationship referenced to 70 kg.

The candidate is not “body weight” alone; it is the specific relationship between body weight and \(CL\). For \(x_i\) measured in kg, the proposed relationship is:

CL_i=CL_{70}\left(\frac{x_i}{70\ \mathrm{kg}}\right)^{\beta_{\mathrm{WT,CL}}}

The ratio of weights is dimensionless, so the right side retains the units of \(CL_{70}\), namely L/h. If the hypothesis is that clearance increases as weight increases, the expected direction is \(\beta_{\mathrm{WT,CL}}>0\). For example, at 84 kg the ratio is \(84/70=1.2\). If a hypothetical candidate coefficient were \(0.75\), then \(CL_i/CL_{70}=1.2^{0.75}\approx1.147\), or about 14.7% higher clearance than at 70 kg. This arithmetic illustrates the direction implied by the parameterization; it does not estimate an effect from study data.

A matrix row could read: parameter \(CL\); covariate baseline weight (kg); rationale: body size may influence drug disposition; availability: recorded at baseline for the planned analysis set; expected direction: positive power coefficient relative to 70 kg; planned test: compare the model with \(\beta_{\mathrm{WT,CL}}=0\) against the model estimating that coefficient. The planned test is recorded in advance; this example does not perform it.

Worked Example: Distinguishing Parameters and Categorical Contrasts

Hypothetical setting. A study records a two-category formulation indicator, with formulation A as the reference and formulation B as the comparison. A scientific hypothesis proposes that formulation may influence apparent bioavailability \(F\), while no specific formulation effect on clearance has been proposed.

A suitable candidate entry names \(F\), not every parameter in the model. One coding is:

\operatorname{logit}(F_i)=\operatorname{logit}(F_A)+\gamma_{\mathrm{B:A}} I(\text{formulation B})

The indicator is 0 for A and 1 for B. Thus, \(\gamma_{\mathrm{B:A}}\) is the modeled log-odds contrast for B relative to A. If the scientific expectation is higher bioavailability for B, the expected direction is \(\gamma_{\mathrm{B:A}}>0\), because the inverse-logit function is increasing. The planned test is a one-degree-of-freedom comparison of the model with \(\gamma_{\mathrm{B:A}}=0\) against the model estimating the contrast.

The matrix should separately record “formulation–\(F\)” and any other genuinely proposed relationship. It should not silently add “formulation–\(CL\)” just because formulation is available. For this hypothetical example, formulation is recorded for every included individual, and the rationale supports a candidate effect on \(F\) only. That is a scoped hypothesis, not a claim that other effects are impossible.

Worked Example: A Small Parameter-by-Covariate Matrix

Hypothetical setting. Consider a model with typical clearance \(CL\) and volume \(V\), and two measured covariates: baseline body weight and a two-category sex variable. For illustration, the team has proposed three relationships. Weight is recorded for all 48 individuals; sex is recorded for 46 of 48. The latter fact is simply an availability note, not a judgment about whether the unrecorded values can be ignored.

Parameter–covariate candidate	Scientific rationale	Availability	Expected direction or contrast	Planned test
Weight–\(CL\)	Body size may relate to drug elimination.	Baseline weight recorded for 48/48.	Positive power coefficient relative to 70 kg.	One-degree-of-freedom comparison with the weight coefficient fixed at zero.
Weight–\(V\)	Body size may relate to distribution volume.	Baseline weight recorded for 48/48.	Positive power coefficient relative to 70 kg.	One-degree-of-freedom comparison with the weight coefficient fixed at zero.
Sex–\(CL\)	A physiological difference could alter clearance; rationale requires clinical support.	Recorded for 46/48; two values unavailable.	Female versus male contrast; no direction specified.	One-degree-of-freedom comparison of the sex contrast with zero.

This table distinguishes two uses of “no direction.” For sex–\(CL\), the team has a candidate rationale but no defensible directional prediction, so the entry says so explicitly. It would be misleading to invent a direction just to fill the cell. The availability note also preserves the fact that the model-building plan needs attention to the two unavailable values; it does not assume a solution or decide whether that candidate should proceed.

The rows for weight–\(CL\) and weight–\(V\) are separate hypotheses. The same covariate can have different evidence and consequences for different parameters, and each relationship needs its own rationale and planned test.

Why the Matrix Improves Model-Building Decisions

The matrix provides a traceable link from scientific reasoning to an implementable model comparison. It also makes a short justification for the design straightforward. If the candidate coefficient is zero, the covariate has no effect under the specified parameterization. For the power model, this follows directly:

\beta_{kj}=0 \quad\Longrightarrow\quad \left(\frac{x_{ij}}{x_{j,\mathrm{ref}}}\right)^{\beta_{kj}}=1 \quad\Longrightarrow\quad \theta_{k,i}=\theta_{k,\mathrm{ref}}.

Thus, comparing a model with the coefficient fixed at zero to one that estimates it targets the stated candidate relationship. The matrix does not establish that the test’s assumptions hold or that the relationship is identified by the data. It simply makes clear what is being proposed and what null value the planned comparison concerns.

A matrix is also more informative than a covariate-only checklist. A checklist might say “test weight,” while the matrix reveals whether the intended test concerns \(CL\), \(V\), or both; whether the same transformation is justified for each; and what direction was anticipated. Conversely, a full model written down immediately can obscure why each term is present. The matrix leaves a visible record of each candidate before those candidates are assembled into a model.

Diagnostics, Alternatives, and Limitations

Inspect the completed matrix for internal consistency before implementing it. A candidate is not ready to test if its parameter, covariate definition, units, reference value, or contrast is ambiguous. Check that the stated direction agrees with the coefficient coding, and that the planned null comparison removes exactly the relationship named in the row. If the same covariate–parameter relationship appears twice under different labels, resolve the duplication rather than treating them as distinct hypotheses.

Another useful check is whether every proposed row has an interpretable rationale and an availability statement. “It was measured” is an availability fact, not a scientific rationale. “The mechanism predicts an effect” is incomplete unless it says which parameter is affected and, where support permits, the expected direction. A missing directional prediction can be recorded honestly; a missing parameter target or an undefined covariate cannot.

The main alternatives are an informal narrative list, a covariate-only table, or writing a full covariate model directly. A narrative can preserve nuance but makes systematic checking difficult. A covariate-only table is compact but hides parameter-specific hypotheses. Writing a full model is useful for implementation, but it can combine candidate decisions before the rationale and planned comparisons have been made explicit. The matrix is most useful when it complements these representations: it documents candidate-level decisions, while a model specification records the terms ultimately implemented.

A matrix has limits. It cannot show that a relationship is real, ensure adequate data support, resolve unavailable measurements, or guarantee that a planned statistical comparison will be reliable. Availability counts alone do not describe why values are unavailable. A rationale may also be uncertain, and a one-direction expectation should not be mistaken for proof or causality. Keep entries specific, mark uncertainty plainly, and revise the record transparently if the scientific plan changes.

Common Pitfall

Common mistake: “Weight is a candidate, so I will add it to the model.” This leaves unspecified which parameter weight affects, how weight enters the model, what direction is expected, and what comparison will evaluate the relationship. The correction is to create a distinct entry for each proposed parameter–weight relationship, state its parameterization and rationale, record availability and expected direction, and name the planned test. A covariate should not be treated as a single undifferentiated model term.

Check Your Understanding

Answer each question using the matrix principles above. Short solutions follow the questions.

In a power model for \(CL\), what does a zero weight coefficient imply for individual clearance?
A candidate row says “age: expected positive effect.” What additional information is needed to make the row interpretable?
A categorical covariate has three levels. Should its matrix entry automatically specify a one-degree-of-freedom test? Explain.
Weight is scientifically proposed for both \(CL\) and \(V\). How should these candidates be recorded?
What does an availability note that a covariate is recorded for 46 of 48 individuals establish, and what does it not establish?

Solutions. (1) The covariate multiplier is \(1\), since any positive weight ratio raised to the zero power is \(1\); thus \(CL_i=CL_{\mathrm{ref}}\) under that relationship. (2) Name the target parameter, define age and its units or measurement time, specify the coding or transformation and reference, give a rationale, record availability, and state the planned comparison. (3) No. A three-level factor generally needs two coefficients under reference-category coding, so a joint test of the factor may have two degrees of freedom; the matrix should state the planned contrast or joint comparison. (4) Record two rows, weight–\(CL\) and weight–\(V\), each with its own rationale, direction, availability, and planned test. (5) It establishes that two of the 48 recorded values are unavailable in the stated dataset; it does not establish why, whether those individuals can be included, or how the unavailable values should be handled.